We make select early investments at the Seed stage in private biotech ventures as the lead or sole investor and participate in Series-A investments.
We launch and fund de novo companies to advance important innovations, which may otherwise lack the proper resources to progress and thrive.
Beyond financial support, we work with our portfolio companies by providing management support and development expertise through a group of highly experienced advisors and operators. Together with our portfolio companies, we identify critical value inflection milestones and develop a plan to successfully arrive there. By leveraging the Tellus BioVentures team, we help companies operate in an efficient manner, focused on achieving milestones and transforming innovative science into important therapies for patients.